Resources

Results 1301 - 1325 of 1389

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, February 2020 edition. 

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, March 2020 edition.

Essential medicines improve health and save lives. However, the complex system that is needed to get them to people does not always function well. Shortages of medical products are common. Poor quality and high costs burden patients and health ministries. Antimicrobial resistance, fed by inappropriate use, is spreading and may greatly undermine progress in global health.

For decades, the lead of the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program consortium, Management Sciences for Health (MSH), has supported governments around the world in building resilient health systems that have the sustainable capability to take coordinated, measurable actions to prevent epidemics, detect biological threats early, and respond rapidly to disease out

Postpartum hemorrhage (PPH) remains one of the major causes of maternal mortality.

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, April 2020 edition. 

The spread of COVID-19 has disrupted lives, communities, and economies worldwide.

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, May 2020 edition. 

Effective pharmacy services improve patient outcomes and satisfaction by ensuring that life-saving products are available and providing care that helps patients use products safely and appropriately.

PV is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other possible medicine-related problems. Adverse effects of medicines, particularly those that are unexpected, can negatively affect patients’ health and quality of life and further strain and undermine trust in the health care delivery system.

It takes a resilient pharmaceutical system working within and in support of a functioning health system to ensure access to products and services for the people who need them. Pharmaceutical system strengthening requires a coordinated response from policy makers to the dispenser at the local drug shop.

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, June 2020 edition. 

Using an effective intervention and district-led approach to strengthen medicine management in government and private not-for-profit health facilities, Supervision, Performance Assessment, and Recognition Strategy (SPARS), the Uganda Health Supply Chain (UHSC) project strengthened the capacity of district health workers to effectively manage and utilize health commodities and promoted local owners

Access to appropriate, high-quality medicines where and when they are needed is the overall goal of a well functioning supply chain and responsive health system.

To ensure an uninterrupted supply of essential medicines and effectively monitor store management in health facilities, the Uganda Ministry of Health (MoH) chose RxSolution, an integrated pharmaceutical management software.

Public pharmaceutical-sector managers in Uganda previously relied on information gathered from multiple sources to plan for and manage health supplies at the national, district, and facility levels. Not easily accessible, these sources required extensive effort to compile factual, real-time evidence for decision making.

A good health system ensures equitable and consistent access to quality essential medicines and health supplies. Health equity is prioritized in Uganda’s National Medicines Policy but unequal resource allocation has resulted in some health facilities having insufficient resources to meet local health needs.

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, July 2020 edition.

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, August 2020 edition. 

Many low-income and middle-income countries lack the capacity to effectively and efficiently regulate medical products in their countries. To support countries in strengthening their capacity, WHO has developed the Global Benchmarking Tool (GBT) as the global standard for objectively assessing regulatory capacity for medicines and vaccines. The GBT is a game changer because it is the first globally accepted tool for assessing and strengthening national regulatory authorities. The inclusion of an institutional development plan in the GBT methodology provides context-specific actionable steps countries can take to advance their system’s functionality and maturity. The GBT facilitates coordination and improves the effectiveness of regulatory strengthening efforts. The tool also facilitates regulatory reliance and harmonisation, which helps to improve timely access to quality-assured medicines, and creates incentives for trade, particularly in countries and regions with a strong pharmaceutical manufacturing base. 

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, September 2020 edition. 

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, October 2020 edition. 

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, November edition. 

Please download to read the USAID Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity in Ukraine News Digest, December 2020 edition. 

Diagnostic tests for COVID-19 fall into three main categories: Molecular, Antigen, and Serological. Each category of tests comes with its own limitations, thus impacting how and where it can be used. Molecular tests based on Polymerase Chain Reaction (PCR) technology are the current ‘gold standard’ for COVID-19 testing.

Pages